Literature DB >> 22507633

Personalized cancer medicine - a strategy to counteract an increasing cancer challenge.

John Mendelsohn, Ulrik Ringborg, Richard L Schilsky.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22507633      PMCID: PMC5528371          DOI: 10.1016/j.molonc.2012.03.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


× No keyword cloud information.
  1 in total

1.  Personalized cancer medicine - a strategy to counteract an increasing cancer challenge.

Authors:  John Mendelsohn; Ulrik Ringborg; Richard L Schilsky
Journal:  Mol Oncol       Date:  2012-03-13       Impact factor: 6.603

  1 in total
  4 in total

1.  Personalized cancer medicine - a strategy to counteract an increasing cancer challenge.

Authors:  John Mendelsohn; Ulrik Ringborg; Richard L Schilsky
Journal:  Mol Oncol       Date:  2012-03-13       Impact factor: 6.603

2.  Preventive evolutionary medicine of cancers.

Authors:  Michael E Hochberg; Frédéric Thomas; Eric Assenat; Urszula Hibner
Journal:  Evol Appl       Date:  2012-12-05       Impact factor: 5.183

Review 3.  Personalizing health care: feasibility and future implications.

Authors:  Brian Godman; Alexander E Finlayson; Parneet K Cheema; Eva Zebedin-Brandl; Inaki Gutiérrez-Ibarluzea; Jan Jones; Rickard E Malmström; Elina Asola; Christoph Baumgärtel; Marion Bennie; Iain Bishop; Anna Bucsics; Stephen Campbell; Eduardo Diogene; Alessandra Ferrario; Jurij Fürst; Kristina Garuoliene; Miguel Gomes; Katharine Harris; Alan Haycox; Harald Herholz; Krystyna Hviding; Saira Jan; Marija Kalaba; Christina Kvalheim; Ott Laius; Sven-Ake Lööv; Kamila Malinowska; Andrew Martin; Laura McCullagh; Fredrik Nilsson; Ken Paterson; Ulrich Schwabe; Gisbert Selke; Catherine Sermet; Steven Simoens; Dominik Tomek; Vera Vlahovic-Palcevski; Luka Voncina; Magdalena Wladysiuk; Menno van Woerkom; Durhane Wong-Rieger; Corrine Zara; Raghib Ali; Lars L Gustafsson
Journal:  BMC Med       Date:  2013-08-13       Impact factor: 8.775

4.  A mission-oriented approach to cancer in Europe: a joint mission/vision 2030.

Authors:  Julio E Celis; Dainius Pavalkis
Journal:  Mol Oncol       Date:  2017-11-09       Impact factor: 6.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.